$BGLC News
Last published 1w ago
- 1w agoBGLCRYETBioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA ScientificGlobeNewswireKUALA LUMPUR, Malaysia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company") today introduced BGLC 1Lab, its laboratory workflow product, and announced
- 1w agoBGLCBioNexus Launches New Corporate Website with Expanded Business and Investor ResourcesGlobeNewswireKUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company") today announced the launch of its redesigned corporate website at
- 1mo agoBGLCRYETBioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI LicenceGlobeNewswireKUALA LUMPUR, Malaysia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("Company" or "BGLC") today announced plans to build AI applications for Malaysian healthcare, following
- 3mo agoBGLCBioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working VisitGlobeNewswireKUALA LUMPUR, Malaysia, July 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company") today announced continued progress toward commercializing the VitaGuard™
- 5mo agoBGLCBioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-DevelopmentGlobeNewswireKUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a technology-focused company advancing innovation across biotechnology, precision
- 8mo agoBGLCBioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as ChairmanGlobeNewswireEnhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluation framework KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC)
- 9mo agoBGLCBioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar MarketGlobeNewswireKUALA LUMPUR, Malaysia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a technology-driven precision diagnostics company, today announced the formal commencement
- 11mo agoBGLCBioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™GlobeNewswireKUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BGLC" or the "Company"), a biotechnology company advancing precision diagnostics and gene-based
- 11mo agoBGLCBioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic CommercializationGlobeNewswireSHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC" or the "Company"), an emerging provider of precision oncology diagnostics with expanding operations across Southeast Asia, today
- 11mo agoBGLCBioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu GeneGlobeNewswireKUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC") today announced that it has executed an Exclusive Intellectual Property License Agreement for Southeast Asia with
- 12mo agoBGLCBioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD CommercializationGlobeNewswireKUALA LUMPUR, Malaysia and SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC, ("BGLC," NASDAQ:BGLC) today announced it has entered into definitive agreements with Fidelion Diagnostics Pte.
- 1y agoBGLCBioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth OpportunitiesGlobeNewswireKUALA LUMPUR, Malaysia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a biotechnology company advancing precision diagnostics and gene-based technologies across
- 1y agoBGLCBioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.GlobeNewswireKUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (NASDAQ:BGLC, "BGLC", or the "Company")), today announced that it has entered into a non-binding Strategic Partnership Term Sheet with
- 1y agoBGLCBioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new "DeepSeek Moment" in Precision OncologyGlobeNewswireKUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BGLC", Nasdaq: BGLC) and Fidelion Diagnostics Pte Ltd, a Singaporean company ("Fidelion") today announced the signing of a term sheet
- 1y agoBGLCBioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth ReadinessGlobeNewswireKUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC), a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it
- 1y agoBGLCBioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth TrajectoryGlobeNewswireKUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a diversified biotechnology and specialty materials group headquartered in Malaysia and
- 1y agoBGLCBioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury StrategyGlobeNewswireKUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership
- 1y agoBGLCBioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic WhitepaperGlobeNewswireKUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce that its Board of
- 2y agoBGLCBioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.GlobeNewswireKUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- MRNA Scientific Sdn. Bhd. ("MRNA"), a subsidiary of BioNexus Gene Lab Corp. (NASDAQ:BGLC, the "Company")), and Protech Builders Sdn. Bhd.
- 2y agoBGLCBioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.GlobeNewswireKUALA LUMPUR, Malaysia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC, the "Company")), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce
- 2y agoBGLCBioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare SolutionsGlobeNewswireKUALA LUMPUR, Malaysia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC, the "Company")), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce the
- 2y agoBGLCBioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste ProductionGlobeNewswireKUALA LUMPUR, Malaysia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (NASDAQ:BGLC, the "Company")), an emerging Biotech & Chemicals company, is pleased to announce that its subsidiary, Chemrex
- 2y agoBGLCBioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn BhdGlobeNewswireKUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC), an emerging leader in genomic diagnostics and personalized medicine, is pleased to announce the successful co-investment
- 2y agoBGLCBioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn BhdGlobeNewswireKUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ:BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM 1
- 2y agoBGLCBioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in HealthcareGlobeNewswireKUALA LUMPUR, Malaysia, April 19, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ:BGLC), a global leader in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly
- 3y agoBGLCBioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital MarketGlobeNewswireKUALA LUMPUR, Malaysia, July 24, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BioNexus" or the "Company") (NASDAQ:BGLC), an emerging company in the business of selling chemical raw materials in the Southeast Asia
- 3y agoBGLCBioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital MarketGlobeNewswireKUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. ("BioNexus" or the "Company"), an emerging company in the business of selling chemical raw materials in the Southeast Asia region and
- 5y agoAAWHACLHFADBRFATBYF+44OTC Markets Group Announces Quarterly Index Performance and RebalancingPR NewswireNEW YORK, Oct. 15, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the third quarter 2021 performance and quarterly rebalancing of the OTCQX® and OTCQB® in